Impact of Glaxo, SmithKline merger on India Economy
The merger of Glaxo India and SmithKline Beecham Pharma will create the second largest pharmaceutical company in India, based on the results for the year ended 31 December 1998, after Ranbaxy Laboratories, with its sales of Rs 1,382.06 crore...
economy
glaxo
glaxo india
glaxo smithkline merger
impact
india
india economy
indian mergers
macro economics
managerial economics
merger
merger and acquisition
smithkline
